Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of CSCJC3456 in Patients With Advanced Malignant Tumors (NCT06717750) | Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. | 2025-02-13 |
| A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues (NCT07057271) | Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. | 2021-05-27 |
| A Study of CJC-1134-PC Injection in Antidiabetic Treatment-naive Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (NCT07058545) | Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. | 2021-04-16 |
Track Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.